Diphtheria Antitoxin (DAT)

Treatment for Diphtheria

Typical Dosage: 20,000-120,000 units IV/IM

Effectiveness
95%
Safety Score
50%
Clinical Trials
1
Participants
7.5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
50
DangerousModerateSafe
Treatment Details
Dosage Range
20,000-120,000 units IV/IM
Time to Effect
Immediate
Treatment Duration
Single administration (can be repeated)
Evidence Quality
MODERATE
Number Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
20(Treat 20 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$2,000
Monitoring:$30,000
Side Effect Mgmt:$1,000
Total Annual:$33,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
15
Outcome-Based Costs
Cost per Responder
$38,823
Cost per Remission
$47,143
Diphtheria Antitoxin (DAT) Outcomes

for Diphtheria

Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+85%
Remission Rate
+70%
Common Side Effects
Serum sickness
+10%
Anaphylaxis
+5%
Local injection site reactions
+25%

Sources:

www.gov.uk
www.gov.uk
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
1 completed trial for Diphtheria Antitoxin (DAT) in Diphtheria

Post Marketing Surveillance of Diphtheria Antitoxin (DAT)

NCT06053853COMPLETEDPHASE4
View Study
68 participants
INTERVENTIONAL
Surabaya, Indonesia
Started: Jan 31, 2023